Lv11
30 积分 2022-09-14 加入
International Cost-Effectiveness Analysis of Durvalumab in Stage III Non–Small Cell Lung Cancer
6小时前
待确认
International Cost-Effectiveness Analysis of Durvalumab in Stage III Non–Small Cell Lung Cancer
2天前
已完结
Cost-effectiveness Analysis of Tumor Treating Fields Therapy Combined With Immune Checkpoint Inhibitor in Metastatic Non-small-cell Lung Cancer
7天前
已完结
Research on Optimization of Grey Wolf Algorithm with Multiple Improved Strategies
13天前
已完结
Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017−2030
20天前
已完结
Combination Therapy for EGFR -Mutated Lung Cancer
20天前
已完结
Expert-consensus on lymphedema surgeries: candidacy, prehabilitation, and postoperative care
29天前
已完结
Advances in Lymphedema
1个月前
已完结
Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
